EP2179744
Dregið úr áhættu við meðferð með inflúensubóluefni.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.9.2005EP published:
1.12.2010EP application number:
09075377.3
EP translation filed:
1.3.2011Grant published:
15.3.2011EPO information:
European Patent Register
Max expiry date:
8.9.2025Expiry date:
8.9.2014
Title:
Decreasing potential latrogenic risks associated with influenza vaccines
Timeline
Today
9.9.2005EP application
1.12.2010EP Publication
1.3.2011Translation submitted
15.3.2011Registration published
8.9.2014Expires
Owner
Name:
Novartis Vaccines and Diagnostics GmbHAddress:
Emil-von-Behring-Strasse 76, 35041, Marburg, DE
Inventor
Name:
Gregersen, Jens PeterAddress:
Marburg, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
04255471Date:
9.9.2004Country:
EP
Classification
Categories:
A61K 39/145, C12Q 1/70
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 11.8.2011
Expires: 8.9.2012
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 8.8.2012
Expires: 8.9.2013
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 8.8.2013
Expires: 8.9.2014
Payer: Árnason Faktor